How many stocks are there of Epigenomics?
The current number of stocks of Epigenomics is 813,320 undefined.
Epigenomics Stocks 2024
Epigenomics Stocks
813,320
Ticker
ECX.DE
ISIN
DE000A3H2184
WKN
A3H218
In 2024, Epigenomics had 813,320 outstanding stocks, a 0% change from the 813,320 stocks in the previous year.
The Epigenomics Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2029e | 0.81 |
| 2028e | 0.81 |
| 2027e | 0.81 |
| 2026e | 0.81 |
| 2025e | 0.81 |
| 2024e | 0.81 |
| 2023e | 0.81 |
| 2022 | 0.81 |
| 2021 | 0.56 |
| 2020 | 0.29 |
| 2019 | 1.18 |
| 2018 | 0.86 |
| 2017 | 0.73 |
| 2016 | 0.54 |
| 2015 | 2.14 |
| 2014 | 13.67 |
| 2013 | 11.94 |
| 2012 | 9.64 |
| 2011 | 9.64 |
| 2010 | 8.83 |
| 2009 | 6.38 |
| 2008 | 5.97 |
| 2007 | 4.09 |
| 2006 | 3.83 |
| 2005 | 3.8 |
| 2004 | 3.2 |
| 2003 | 1.96 |
Epigenomics shares outstanding DE000A3H2184 · A3H218
The number of shares was Epigenomics in 2023 — This indicates how many shares 813,320 is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Epigenomics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Epigenomics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Epigenomics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Epigenomics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2003 | 1.96 M Aktien |
| 2004 | 3.2 M Aktien |
| 2005 | 3.8 M Aktien |
| 2006 | 3.83 M Aktien |
| 2007 | 4.09 M Aktien |
| 2008 | 5.97 M Aktien |
| 2009 | 6.38 M Aktien |
| 2010 | 8.83 M Aktien |
| 2011 | 9.64 M Aktien |
| 2012 | 9.64 M Aktien |
| 2013 | 11.94 M Aktien |
| 2014 | 13.67 M Aktien |
| 2015 | 2.14 M Aktien |
| 2016 | 543,000 Aktien |
| 2017 | 734,750 Aktien |
| 2018 | 856,650 Aktien |
| 2019 | 1.18 M Aktien |
| 2020 | 293,300 Aktien |
| 2021 | 560,370 Aktien |
| 2022 | 813,320 Aktien |
| 2023e | 813,320 Aktien |
| 2024e | 813,320 Aktien |
| 2025e | 813,320 Aktien |
| 2026e | 813,320 Aktien |
| 2027e | 813,320 Aktien |
| 2028e | 813,320 Aktien |
| 2029e | 813,320 Aktien |
Epigenomics Aktienanalyse
What does Epigenomics do?
Epigenomics AG is a German biotechnology company specializing in the development of diagnostics for the early detection of cancer. The company is headquartered in Berlin and was founded in 1997. Epigenomics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Epigenomics's Shares Outstanding
Epigenomics's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Epigenomics’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Epigenomics’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Epigenomics’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Epigenomics stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Epigenomics are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Epigenomics evolved in recent years?
The number of shares of Epigenomics has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Epigenomics as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Epigenomics?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Epigenomics pay?
Over the past 12 months, Epigenomics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Epigenomics is expected to pay a dividend of 0 EUR.
What is the dividend yield of Epigenomics?
The current dividend yield of Epigenomics is .
When does Epigenomics pay dividends?
Epigenomics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Epigenomics?
Epigenomics paid dividends every year for the past 0 years.
What is the dividend of Epigenomics?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Epigenomics located?
Epigenomics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Epigenomics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Epigenomics from 12/19/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.
When did Epigenomics pay the last dividend?
The last dividend was paid out on 12/19/2024.
What was the dividend of Epigenomics in the year 2023?
In the year 2023, Epigenomics distributed 0 EUR as dividends.
In which currency does Epigenomics pay out the dividend?
The dividends of Epigenomics are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Epigenomics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Epigenomics
Our stock analysis for Epigenomics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Epigenomics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
